Home > Research > Browse

Research

Results for Triple Negative Breast Neoplasms/drug therapy

Publications & Outputs

  1. Isolation of a jadomycin incorporating L-ornithine, analysis of antimicrobial activity and jadomycin reactive oxygen species (ROS) generation in MDA-MB-231 breast cancer cells

    Forget, S. M., Robertson, A. W., Hall, S. R., MacLeod, J. M., Overy, D. P., Kerr, R. G., Goralski, K. B. & Jakeman, D. L., 26/04/2018, In: The Journal of antibiotics. 71, 8, p. 722-730 9 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  2. Jadomycins Inhibit Type II Topoisomerases and Promote DNA Damage and Apoptosis in Multidrug-Resistant Triple-Negative Breast Cancer Cells

    Hall, S. R., Toulany, J., Bennett, L. G., Martinez-Farina, C. F., Robertson, A. W., Jakeman, D. L. & Goralski, K. B., 1/11/2017, In: Journal of Pharmacology and Experimental Therapeutics. 363, 2, p. 196-210 15 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review